Tayfun Ozcelik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tayfun Ozcelik has a total of 737 co-authors. Here are the top co-authors by number of shared publications:
- Jean-Laurent Casanova
University of Texas Southwestern 1 Laboratory of Human Genetics of Infectious Diseases Dallas, TX
12 shared publications - Aurélie Cobat
Necker Branch, INSERM UMR 1163 3 Laboratory of Human Genetics of Infectious Diseases, Institut Imagine, Université Paris Cité Paris
11 shared publications - Laurent Abel
St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, Rockefeller University, New York, NY, USA
10 shared publications - Emmanuelle Jouanguy
Imagine Institute, University of Paris Cité
7 shared publications - Isabelle Meyts
Department of Microbiology, Immunology and Transplantation, Laboratory for Inborn Errors of Immunity, KU Leuven, Leuven, Belgium
6 shared publications - Lucy Bizien
Laboratory of Human Genetics of Infectious Diseases, https://ror.org/05tr67282Necker Branch, INSERM U1163, Necker Hospital for Sick Children, Paris, France
6 shared publications
Latest Publications
- Open Access
Gene-based map of cardiovascular diseases
Background: Rare coding variants contribute to cardiovascular disease, but their effects across disease groups remain incompletely characterized. In particular, the influence of functionally and clinically informed variant classification and sex-specific genetic effects on gene–phenotype associations remains understudied. Methods: We analyzed whole-genome sequencing data from up to 483,311 UK Biobank participants across six genetic ancestry groups and eight cardiovascular phenotype groups. Gene-burden testing integrated state-of-the-art missense classification and predicted pathogenic germline variants. We performed combined-sex and sex-stratified analyses, followed by cross-ancestry meta-analysis. We additionally adjusted for cardiometabolic traits in sensitivity analyses, estimated penetrance among qualifying-variant carriers, and assessed genetic prevalence across eight ancestry groups. Results: We identified 86 exome-wide significant gene–phenotype associations: 40 established and 46 novel. Novel associations included EHMT2 with atrial fibrillation, P2RX1 with arrhythmias, P2RY4 with complete atrioventricular block, and NOSTRIN with atherosclerotic heart disease in females. After cardiometabolic adjustment, 60 associations retained exome-wide significance and 18 additional associations emerged, including CDH11 , PARVA , and ADAMDEC1 with atherosclerosis-related phenotypes. Conclusions: These findings identify novel cardiovascular gene–phenotype associations implicating purinergic signaling, endothelial nitric oxide regulation, and vascular wall biology. Variant selection shapes penetrance estimates and the interpretation of inherited susceptibility.
Open AccessGene-based map of cardiovascular diseases
Background: Rare coding variants contribute to cardiovascular disease, but their effects across disease groups remain incompletely characterized. In particular, the influence of functionally and clinically informed variant classification and sex-specific genetic effects on gene–phenotype associations remains understudied. Methods: We analyzed whole-genome sequencing data from up to 483,311 UK Biobank participants across six genetic ancestry groups and eight cardiovascular phenotype groups. Gene-burden testing integrated state-of-the-art missense classification and predicted pathogenic germline variants. We performed combined-sex and sex-stratified analyses, followed by cross-ancestry meta-analysis. We additionally adjusted for cardiometabolic traits in sensitivity analyses, estimated penetrance among qualifying-variant carriers, and assessed genetic prevalence across eight ancestry groups. Results: We identified 86 exome-wide significant gene–phenotype associations: 40 established and 46 novel. Novel associations included EHMT2 with atrial fibrillation, P2RX1 with arrhythmias, P2RY4 with complete atrioventricular block, and NOSTRIN with atherosclerotic heart disease in females. After cardiometabolic adjustment, 60 associations retained exome-wide significance and 18 additional associations emerged, including CDH11 , PARVA , and ADAMDEC1 with atherosclerosis-related phenotypes. Conclusions: These findings identify novel cardiovascular gene–phenotype associations implicating purinergic signaling, endothelial nitric oxide regulation, and vascular wall biology. Variant selection shapes penetrance estimates and the interpretation of inherited susceptibility.
- 26 August 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (9) , 2350-2360
Prediction of human missense variant effects from functional evidence
- 26 August 2026
- Published by Springer Nature in Nature Genetics
- Vol. 58 (9) , 2350-2360
Prediction of human missense variant effects from functional evidence
- Open Access
- 16 July 2026
- Published by Springer Nature in Research Square
Gene-based map of cardiometabolic diseases
Cardiometabolic disorders are common, interrelated conditions with substantial genetic contribution. We performed sex- and ancestry-stratified rare-variant gene-burden analyses in UK Biobank across obesity, fatty liver disease, dyslipidemia, hypertension, chronic kidney disease, and diabetes mellitus, with Turkish Variome contributing to obesity analyses, using state-of-the-art variant classification tools. This approach replicated established gene–phenotype relationships and expanded the number of causal cardiometabolic gene–phenotype associations from 368 to 534. Complementary genetic-epidemiological analyses showed that approximately one in six individuals carries risk-increasing alleles and one in nine carries protective alleles.
- 16 July 2026
- Published by Springer Nature in Research Square
Open AccessGene-based map of cardiometabolic diseases
Cardiometabolic disorders are common, interrelated conditions with substantial genetic contribution. We performed sex- and ancestry-stratified rare-variant gene-burden analyses in UK Biobank across obesity, fatty liver disease, dyslipidemia, hypertension, chronic kidney disease, and diabetes mellitus, with Turkish Variome contributing to obesity analyses, using state-of-the-art variant classification tools. This approach replicated established gene–phenotype relationships and expanded the number of causal cardiometabolic gene–phenotype associations from 368 to 534. Complementary genetic-epidemiological analyses showed that approximately one in six individuals carries risk-increasing alleles and one in nine carries protective alleles.
- 15 July 2026
- Published by Elsevier in Genetics in Medicine
- Vol. 28 (10) , 102624
AAVC: An automated framework for high-accuracy ACMG-based variant classification
- 15 July 2026
- Published by Elsevier in Genetics in Medicine
- Vol. 28 (10) , 102624
AAVC: An automated framework for high-accuracy ACMG-based variant classification
- Open Access
- 26 May 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1796664
A homozygous missense variant, p.Ser166Leu in the PRPF40B gene, in a 7.7 Mb region of homozygosity in a consanguineous Turkish family with essential tremor
Introduction: We leveraged consanguinity and population endogamy in a large four generation Turkish family with ET. Examination of clinical features and genetic analysis identified a homozygous PRPF40B missense variant, in a large region of homozygosity, segregating with ET in the family. Methods: The ET family is of Turkish origin. The proband and relatives were evaluated at Ankara University Medical School and Bilkent University (Ankara, Turkey). A second evaluation of the clinical and videotape data was performed at Yale University. A total of 6 individuals from the family were clinically assessed. Whole genome sequencing and autozygosity mapping was performed in affected and unaffected family members. Transient transfection of HEK293T cells was performed to assess pathogenicity of the PRPF40B missense variant. Results: A total of 4 family members were diagnosed with ET; two individuals also had a diagnosis of Parkinson’s Disease (PD). We identified a missense variant in PRPF40B , p.Ser166Leu, located within a 7.7 Mb region of homozygosity (ROH) (Chr12: 46595701–54,330,441), which was observed in all analyzed affected family members. Unlike wildtype PRPF40B which localizes to nuclear speckles in the nuclear compartment, when mutant PRPF40B was expressed in HEK293T cells we observed enrichment and localization to the nuclear membrane. Discussion: The PRPF40B p.Ser166Leu variant is located within a conserved region of the WW protein domain. In Silico pathogenicity and functional studies predict that the missense variant alters the function of PRPF40B . PRPF40B has previously been implicated in the pathogenesis of neurological disorders, including Huntington’s disease and Rett syndrome.
- 26 May 2026
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 17, 1796664
Open AccessA homozygous missense variant, p.Ser166Leu in the PRPF40B gene, in a 7.7 Mb region of homozygosity in a consanguineous Turkish family with essential tremor
Introduction: We leveraged consanguinity and population endogamy in a large four generation Turkish family with ET. Examination of clinical features and genetic analysis identified a homozygous PRPF40B missense variant, in a large region of homozygosity, segregating with ET in the family. Methods: The ET family is of Turkish origin. The proband and relatives were evaluated at Ankara University Medical School and Bilkent University (Ankara, Turkey). A second evaluation of the clinical and videotape data was performed at Yale University. A total of 6 individuals from the family were clinically assessed. Whole genome sequencing and autozygosity mapping was performed in affected and unaffected family members. Transient transfection of HEK293T cells was performed to assess pathogenicity of the PRPF40B missense variant. Results: A total of 4 family members were diagnosed with ET; two individuals also had a diagnosis of Parkinson’s Disease (PD). We identified a missense variant in PRPF40B , p.Ser166Leu, located within a 7.7 Mb region of homozygosity (ROH) (Chr12: 46595701–54,330,441), which was observed in all analyzed affected family members. Unlike wildtype PRPF40B which localizes to nuclear speckles in the nuclear compartment, when mutant PRPF40B was expressed in HEK293T cells we observed enrichment and localization to the nuclear membrane. Discussion: The PRPF40B p.Ser166Leu variant is located within a conserved region of the WW protein domain. In Silico pathogenicity and functional studies predict that the missense variant alters the function of PRPF40B . PRPF40B has previously been implicated in the pathogenesis of neurological disorders, including Huntington’s disease and Rett syndrome.
- Open Access
- 18 February 2026
- Published by Springer Nature in npj Genomic Medicine
- Vol. 11 (1)
Inherited burden for disease predisposition in diverse populations
We leveraged allele frequencies from gnomAD, Regeneron Genetics Center Million Exome and Turkish Variome for 4591 disease genes from PanelApp and OMIM, and identified 97,135 pathogenic and 478,263 likely pathogenic variants using an American College of Medical Genetics and Genomics-based classifier. This expanded pathogenic and likely pathogenic variants nearly six-fold. On average, an individual is born with 4.70 pathogenic or likely pathogenic variants, of which 1.66 are compatible with a Mendelian condition at the genotype level; 1 in 11 has an actionable genotype, and 382 genes are candidates for carrier screening. A genome-first approach revealed the likelihood of having a genotype compatible with disease in 13 ICD-10 disease groups, for example, congenital (1 in 2.70), musculoskeletal/connective (1 in 3.00) and blood/immune (1 in 3.07 individuals). Evidence-based genetic epidemiology demonstrates the potential of personalized medicine for the implementation of early preventive measures and incentivization of lifestyle changes to enhance healthspan and lifespan.
- 18 February 2026
- Published by Springer Nature in npj Genomic Medicine
- Vol. 11 (1)
Open AccessInherited burden for disease predisposition in diverse populations
We leveraged allele frequencies from gnomAD, Regeneron Genetics Center Million Exome and Turkish Variome for 4591 disease genes from PanelApp and OMIM, and identified 97,135 pathogenic and 478,263 likely pathogenic variants using an American College of Medical Genetics and Genomics-based classifier. This expanded pathogenic and likely pathogenic variants nearly six-fold. On average, an individual is born with 4.70 pathogenic or likely pathogenic variants, of which 1.66 are compatible with a Mendelian condition at the genotype level; 1 in 11 has an actionable genotype, and 382 genes are candidates for carrier screening. A genome-first approach revealed the likelihood of having a genotype compatible with disease in 13 ICD-10 disease groups, for example, congenital (1 in 2.70), musculoskeletal/connective (1 in 3.00) and blood/immune (1 in 3.07 individuals). Evidence-based genetic epidemiology demonstrates the potential of personalized medicine for the implementation of early preventive measures and incentivization of lifestyle changes to enhance healthspan and lifespan.
- Open Access
- 3 October 2025
- Published by Springer Nature in Research Square
Prediction of human missense variant effects from functional evidence
Prediction of missense variant effects remains the critical bottleneck in disease gene identification and clinical interpretation. Current predictors rely on clinical outcomes or population patterns, rather than direct measures of functional impact, leading to limited generalizability and data circularity. We present FuncVEP, the first family of variant effect predictors trained exclusively on balanced and diverse functional data, providing a direct representation of functional effect. FuncVEP generalizes across contexts, outperforming 47 existing predictors on both clinical and functional benchmarks, improving the accuracy from 82% to 93% and reducing uncertain classifications from 11% to 2%. To illustrate its utility in gene discovery, we applied FuncVEP to 490 inborn errors of immunity genes in the UK Biobank and Mount Sinai Million Health Discoveries Program, identifying 50 novel gene–phenotype associations. FuncVEP provides a robust, scalable solution for variant interpretation, advancing both diagnostic precision and gene discovery.
- 3 October 2025
- Published by Springer Nature in Research Square
Open AccessPrediction of human missense variant effects from functional evidence
Prediction of missense variant effects remains the critical bottleneck in disease gene identification and clinical interpretation. Current predictors rely on clinical outcomes or population patterns, rather than direct measures of functional impact, leading to limited generalizability and data circularity. We present FuncVEP, the first family of variant effect predictors trained exclusively on balanced and diverse functional data, providing a direct representation of functional effect. FuncVEP generalizes across contexts, outperforming 47 existing predictors on both clinical and functional benchmarks, improving the accuracy from 82% to 93% and reducing uncertain classifications from 11% to 2%. To illustrate its utility in gene discovery, we applied FuncVEP to 490 inborn errors of immunity genes in the UK Biobank and Mount Sinai Million Health Discoveries Program, identifying 50 novel gene–phenotype associations. FuncVEP provides a robust, scalable solution for variant interpretation, advancing both diagnostic precision and gene discovery.
- Open Access
- 30 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 10 (107) , eads7377
Human LY9 governs CD4 + T cell IFN-γ immunity to Mycobacterium tuberculosis
CD4 + T cells are indispensable for optimal immunity to Mycobacterium tuberculosis ( M.tb ), a pathogen that triggers tuberculosis (TB) in humans. M.tb -specific human CD4 + T cells are known to polarize toward an interferon-γ (IFN-γ)–producing, CCR4 − CCR6 + CXCR3 + T-bet + RORγT + T helper 1* cell (T H 1*cell) memory phenotype. We report that autosomal recessive deficiency of the human lymphocytic surface receptor LY9 (SLAMF3 and CD229), which is found in less than 10 −5 individuals in the general population, underlies TB in three unrelated patients due to selective impairment in IFN-γ production by T H 1* cells. T H 1* cells express higher levels of LY9 than other CD4 + T cells. Mechanistically, LY9 polarizes naïve CD4 + T cells toward memory T H 1* cells by inducing T-bet via signaling lymphocytic activation molecule (SLAM)–associated protein (SAP) and RORγT (thymus-specific retinoid-related orphan receptor γ) without SAP. LY9 costimulation enhances TCR-driven IFN-γ production of memory T H 1*, but not T H 1, cells in a T cell–intrinsic manner via NFAT1 (nuclear factor of activated T cells 1) and RORγT. LY9 is likely to govern an optimal T H 1* cell– and IFN-γ–dependent protective immunity to M.tb in humans.
- 30 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 10 (107) , eads7377
Open AccessHuman LY9 governs CD4 + T cell IFN-γ immunity to Mycobacterium tuberculosis
CD4 + T cells are indispensable for optimal immunity to Mycobacterium tuberculosis ( M.tb ), a pathogen that triggers tuberculosis (TB) in humans. M.tb -specific human CD4 + T cells are known to polarize toward an interferon-γ (IFN-γ)–producing, CCR4 − CCR6 + CXCR3 + T-bet + RORγT + T helper 1* cell (T H 1*cell) memory phenotype. We report that autosomal recessive deficiency of the human lymphocytic surface receptor LY9 (SLAMF3 and CD229), which is found in less than 10 −5 individuals in the general population, underlies TB in three unrelated patients due to selective impairment in IFN-γ production by T H 1* cells. T H 1* cells express higher levels of LY9 than other CD4 + T cells. Mechanistically, LY9 polarizes naïve CD4 + T cells toward memory T H 1* cells by inducing T-bet via signaling lymphocytic activation molecule (SLAM)–associated protein (SAP) and RORγT (thymus-specific retinoid-related orphan receptor γ) without SAP. LY9 costimulation enhances TCR-driven IFN-γ production of memory T H 1*, but not T H 1, cells in a T cell–intrinsic manner via NFAT1 (nuclear factor of activated T cells 1) and RORγT. LY9 is likely to govern an optimal T H 1* cell– and IFN-γ–dependent protective immunity to M.tb in humans.
- Open Access
- 16 December 2024
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (2)
A common form of dominant human IFNAR1 deficiency impairs IFN-α and -ω but not IFN-β-dependent immunity
Autosomal recessive deficiency of the IFNAR1 or IFNAR2 chain of the human type I IFN receptor abolishes cellular responses to IFN-α, -β, and -ω, underlies severe viral diseases, and is globally very rare, except for IFNAR1 and IFNAR2 deficiency in Western Polynesia and the Arctic, respectively. We report 11 human IFNAR1 alleles, the products of which impair but do not abolish responses to IFN-α and -ω without affecting responses to IFN-β. Ten of these alleles are rare in all populations studied, but the remaining allele (P335del) is common in Southern China (minor allele frequency ≈2%). Cells heterozygous for these variants display a dominant phenotype in vitro with impaired responses to IFN-α and -ω, but not -β, and viral susceptibility. Negative dominance, rather than haploinsufficiency, accounts for this dominance. Patients heterozygous for these variants are prone to viral diseases, attesting to both the dominance of these variants clinically and the importance of IFN-α and -ω for protective immunity against some viruses.
- 16 December 2024
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 222 (2)
Open AccessA common form of dominant human IFNAR1 deficiency impairs IFN-α and -ω but not IFN-β-dependent immunity
Autosomal recessive deficiency of the IFNAR1 or IFNAR2 chain of the human type I IFN receptor abolishes cellular responses to IFN-α, -β, and -ω, underlies severe viral diseases, and is globally very rare, except for IFNAR1 and IFNAR2 deficiency in Western Polynesia and the Arctic, respectively. We report 11 human IFNAR1 alleles, the products of which impair but do not abolish responses to IFN-α and -ω without affecting responses to IFN-β. Ten of these alleles are rare in all populations studied, but the remaining allele (P335del) is common in Southern China (minor allele frequency ≈2%). Cells heterozygous for these variants display a dominant phenotype in vitro with impaired responses to IFN-α and -ω, but not -β, and viral susceptibility. Negative dominance, rather than haploinsufficiency, accounts for this dominance. Patients heterozygous for these variants are prone to viral diseases, attesting to both the dominance of these variants clinically and the importance of IFN-α and -ω for protective immunity against some viruses.
- Open Access
- 22 November 2024
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 221 (12)
Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C)
Multisystem inflammatory syndrome in children (MIS-C) is a rare condition following SARS-CoV-2 infection associated with intestinal manifestations. Genetic predisposition, including inborn errors of the OAS-RNAseL pathway, has been reported. We sequenced 154 MIS-C patients and utilized a novel statistical framework of gene burden analysis, “burdenMC,” which identified an enrichment for rare predicted-deleterious variants in BTNL8 (OR = 4.2, 95% CI: 3.5–5.3, P < 10−6). BTNL8 encodes an intestinal epithelial regulator of Vγ4+γδ T cells implicated in regulating gut homeostasis. Enrichment was exclusive to MIS-C, being absent in patients with COVID-19 or bacterial disease. Using an available functional test for BTNL8, rare variants from a larger cohort of MIS-C patients (n = 835) were tested which identified eight variants in 18 patients (2.2%) with impaired engagement of Vγ4+γδ T cells. Most of these variants were in the B30.2 domain of BTNL8 implicated in sensing epithelial cell status. These findings were associated with altered intestinal permeability, suggesting a possible link between disrupted gut homeostasis and MIS-C-associated enteropathy triggered by SARS-CoV-2.
- 22 November 2024
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 221 (12)
Open AccessHeterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C)
Multisystem inflammatory syndrome in children (MIS-C) is a rare condition following SARS-CoV-2 infection associated with intestinal manifestations. Genetic predisposition, including inborn errors of the OAS-RNAseL pathway, has been reported. We sequenced 154 MIS-C patients and utilized a novel statistical framework of gene burden analysis, “burdenMC,” which identified an enrichment for rare predicted-deleterious variants in BTNL8 (OR = 4.2, 95% CI: 3.5–5.3, P < 10−6). BTNL8 encodes an intestinal epithelial regulator of Vγ4+γδ T cells implicated in regulating gut homeostasis. Enrichment was exclusive to MIS-C, being absent in patients with COVID-19 or bacterial disease. Using an available functional test for BTNL8, rare variants from a larger cohort of MIS-C patients (n = 835) were tested which identified eight variants in 18 patients (2.2%) with impaired engagement of Vγ4+γδ T cells. Most of these variants were in the B30.2 domain of BTNL8 implicated in sensing epithelial cell status. These findings were associated with altered intestinal permeability, suggesting a possible link between disrupted gut homeostasis and MIS-C-associated enteropathy triggered by SARS-CoV-2.